Synchronous cancer duplicities of pancreas and stomach/kidney and their surgical treatment
Authors:
M. Ghothim 1; R. Havlík 2; P. Skalický 1
; Dušan Klos 2
; R. Vrba 2; J. Strážnická 3; L. Skopal 4; Č. Neoral 1; M. Loveček 1
Authors place of work:
I. chirurgická klinika LF Univerzity Palackého, Olomouc, přednosta: prof. MUDr. Č. Neoral, CSc.
1; I. chirurgická klinika FN Olomouc, přednosta: prof. MUDr. Č. Neoral, CSc.
2; Onkologická klinika LF Univerzity Palackého, Olomouc, přednosta: prof. MUDr. B. Melichar, PhD.
3; Centrum klinické onkologie, Přerov, vedoucí: MUDr. L. Skopal
4
Published in the journal:
Rozhl. Chir., 2015, roč. 94, č. 6, s. 251-255.
Category:
Case Report
Summary
Introduction:
The occurence of synchronous pancreatic cancer and other primary cancer is not frequent and reaches about 5.6% as reported in autoptic studies. Double resections of the pancreas with another organ due to synchronous malignancies have been published only in quite sporadic sets of cases or individual case reports. The authors present three cases of synchronous pancreatic malignancies and stomach or renal cancers treated with surgery, including results and survival.
Cases:
Three patients with synchronous double cancer were identified in a series of 400 pancreatic resections (2006−2014). Two patients presented with symptoms of pancreatic periampullary tumors (bile duct obstruction , weight loss and abdominal pain). The second malignancies were identified as incidental during diagnostic work-up (asymptomatic cancer of the stomach, kidney). Pancreatoduodenectomies (PDE) with lymphadenectomies were performed due to ductal adenocarcinomas (pT2N1M0 G3 and pT3N1M0 G2). The second procedures included subtotal gastrectomy with lymphadenectomy (gastric adenocarcinoma pT1N1M0, G2) and nephrectomy (renal papillary carcinoma pT1bN0M0, G3). Postoperative adjuvant chemotherapy with gemcitabine was given in both patients. Survival rates were 12 and 19 months, respectively. The third patient suffered from abdominal pain and weight loss. Diagnostic work-up revealed stomach carcinoma and early pancreatic adenocarcinoma. Double resection – subtotal gastrectomy with lymphadenectomy and pancreatoduodenectomy with lymphadenectomy – was performed. Gastric adenocarcinoma pT2N2M0, G3 and pancreatic ductal papillary-mucinous adenocarcinoma pT2N0M0, G1 were found in the specimens. Adjuvant radiochemotherapy with 5-fluorouracil and leukovorine was given postoperatively. This patient is still alive nearly 5 years after the surgery, without any reccurence.
Conclusion:
The survival of patients with double synchronous pancreatic malignancies and other primary tumors in our set seems to be influenced by the stage and biology of pancreatic cancer. The survival was worse when the duplicity was presented with symptoms of pancreatic cancer. Pancreatic cancer found incidentally when another malignancy is presented has more favourable results.
Key words:
Pancreatic carcinoma − synchronous cancer − double primary carcinoma − renal cancer − stomach cancer
Zdroje
1. Li Destri G, Giarrizzo A, Bellavia N, et al. Synchronous double cancers of the colon and the pancreas: a case report. Eur Rev Med Pharmacol Sci 2014;18(2 Suppl):28−31.
2. Eriguchi N, Aoyagi S, Hara M, et al. Synchronous or metachronous double cancers of the pancreas and other organs: Report on 12 cases. Surg Today 2000;30:718−21.
3. Gerdes B, Ziegler A, Ramaswamy A, et al. Multiple primaries in pancreatic cancer patients: Indicator of a genetic predisposition? Int J Epidemiol 2000;29:999–1003.
4. Grundmann RT, Meyer F. Second primary malignancy among cancer survivors – epidemiology, prognosis and clinical relevance. Zentralbl Chir 2012;137:565−74.
5. Müller SA, Pahernik S, Hinz U, et al. Renal tumors and second primary pancreatic tumors: a relationship with clinical impact? Patient Saf Surg 2012,6:18.
6. Eriguchi N, Aoyagi S, Hara M, et al. Synchronous or metachronous double cancers of the pancreas and other organs: Report on 12 cases. Surg Today 2000;30:718−21.
7. Ha TK, An JY, Youn HG et al. Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J 2007;48:981−7.
8. Porena M, Vespasiani G, Rosi P, et al. Incidentally detected renal cell carcinoma: role of ultrasonography. J. Clin Utrasound 1992;20:395−400.
9. Ohtani H, Yashino M, Onoda N, et al. Synchronous multiple primary gastrointestinal cancer exhibits frequent microsatellite instability. Int J Cancer 2000;86:678−83.
10. Goggins M, Offerhaus GJ, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998;152:1501−7.
11. Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 2015;2;347(6217):78-81.
12. Makino T, Konishi Y, Takahashi S, et al. Clinicopathology of pancreatic cancer analyzed from annual of the pathological autopsy cases in Japan. Tan To Sui (J Gall Pancr) 5:761−8.
13. Hoar SK, Wilson J, Blot WJ, et al. Second cancer following cancer of the digestive system in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985;68:49–82.
14. Sasaki E, Kushida S, Okinaka T, et al. Case report of double cancer of the pancreas and the kidney with polyposis of the large intestine in Japanese. Gan No Rinsha 1969;15:203−6.
15. Alexakis N, Bosonnet L, Connor S, et al. Double resection for patients with pancreatic cancer and a second primary renal cell cancer. Dig Surg 2003;205:428−32.
16. Olgyai G, Haulik L, Oláh A. Double resection for synchronous pancreatic and renal cell cancer-case report. Magy Seb 2004;57:287−9.
17. Brinster DR, Raper SE. Synchronous colon and pancreatic cancers in patients with Peutz-Jeghers syndrome: report of a case and review of the literature. Surgery 2004;135:352–4.
18. ÚZIS ČR, www.svod.cz
19. Urban O, Fojtík P, Kliment M, et al. Endoskopická léčba časného karcinomu žaludku: vlastní výsledky v období let 2000–2009. Endoskopie 2009;18:156–60.
20. Kourie HR, Markoutsaki N, Roussel H, et al. Double pancreatic and gastric adenocarcinomas: A rare association. Clin Res Hepatol Gastroenterol 2013; 37:137−40.
21. Wang P, Meng ZQ, Chen Z, et al. Survival rate of pancreatic cancer in elderly patients. Hepatogastroenterology 2008;55:681−6.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2015 Číslo 6
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Acute abdominal surgery in pregnancy – as viewed by the surgeon
- Current standards of care in the management of patients with abdominal sepsis
- Ganglioneuroma, a rare cause of soft neck tissues tumor in adult age
- A novel method of endovascular aneurysm sealing (EVAS) in patients with abdominal aortic aneurysm